(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.04%) $82.60
(1.82%) $2.07
(-0.65%) $2 342.40
(-1.46%) $27.26
(-0.16%) $960.00
(0.18%) $0.934
(0.28%) $11.01
(0.14%) $0.797
(0.01%) $93.31
Live Chart Being Loaded With Signals
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States...
Stats | |
---|---|
今日成交量 | 238 785 |
平均成交量 | 5.88M |
市值 | 654 187 |
EPS | $0 ( 2024-04-04 ) |
下一个收益日期 | ( $-0.120 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0100 |
ATR14 | $0.00100 (8.33%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-09 | Perry David P | Buy | 839 895 | Common Stock |
2024-01-09 | Perry David P | Buy | 1 471 453 | Common Stock |
2023-12-18 | Perry David P | Buy | 3 750 | Common Stock |
2023-12-18 | Carmona Richard H | Buy | 3 750 | Common Stock |
2023-12-18 | Lavizzo-mourey Risa J | Buy | 3 750 | Common Stock |
INSIDER POWER |
---|
99.11 |
Last 98 transactions |
Buy: 15 006 415 | Sell: 72 086 |
Better Therapeutics, Inc. 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $-2.73M (0.00 %) |
EPS: | $-1.690 |
FY | 2022 |
营收: | $0 |
毛利润: | $-2.73M (0.00 %) |
EPS: | $-1.690 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.709 |
FY | 2020 |
营收: | $8 000.00 |
毛利润: | $-674 000 (-8 425.00 %) |
EPS: | $-0.334 |
Financial Reports:
No articles found.
Better Therapeutics, Inc.
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。